Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer harboring uncommon EGFR mutations: Focus on afatinib

Details 詳細情報について

• CRID

  1360011144643362560

• DOI

  10.1053/j.seminoncol.2019.08.004

• ISSN

  00937754

• Web Site

  https://api.elsevier.com/content/article/PII:S009377541830191X?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S009377541830191X?httpAccept=text/plain

• Data Source

  • Crossref